Elise Morawiec

TL;DR: In patients with nonhypercapnic acute hypoxemic respiratory failure, treatment with high-flow oxygen, standard oxygen, or noninvasive ventilation did not result in significantly different intubation rates, and there was a significant difference in favor of high- flow oxygen in 90-day mortality.

TL;DR: The clinical characteristics and outcomes of patients with respiratory failure and COVID-19 treated with ECMO were established and ECMO should be considered for patients developing refractory respiratory failure despite optimised care.

TL;DR: Anakinra did not improve outcomes in patients with mild-to-moderate COVID-19 pneumonia, and further studies are needed to assess the efficacy of anakinra in other selected groups of patients with more severe CO VID-19.

TL;DR: Sodium bicarbonate decreased the primary composite outcome and day 28 mortality in the a-priori defined stratum of patients with acute kidney injury, and metabolic alkalosis, hypernatraemia, and hypocalcaemia were observed more frequently in the bic carbonate group than in the control group, with no life-threatening complications reported.

TL;DR: Two patterns including white matter enhancing lesions and basal ganglia abnormalities that could be related to SARS-CoV-2 infection are identified that are related to COVID-19 patients with neurological manifestations.